Clinical Trials Browser

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Neoplasm Metastasis

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Urinary Bladder Neoplasms

Metastatic Urothelial Cancer

Breast Neoplasms

Urinary Bladder Neoplasms

Advanced Solid Tumour

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

Pancreatic Neoplasms

Lymphoma, Large B-Cell, Diffuse

Infiltrating Bladder Urothelial Carcinoma

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Urinary Bladder Neoplasms

Adenocarcinoma, Carcinoma, Pancreatic Ductal

Lung Neoplasms

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Biliary Tract Neoplasms, Stomach Neoplasms

Breast Neoplasms

Biliary Tract Neoplasms

Hodgkin Disease

Pancreatic Neoplasms

Bile Duct Neoplasms, Cholangiocarcinoma

Endometrial Neoplasms

Neoplasm Metastasis

Advanced Biliary Tract Carcinoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Muscle Invasive Bladder Cancer (MIBC)

Carcinoma, Non-Small-Cell Lung

Pancreatic cancer, adult, Pancreatic Neoplasms

Biliary Tract Neoplasms, Carcinoma

Hodgkin Disease, Recurrence

Cholangiocarcinoma

Cholangiocarcinoma

Metastatic Pancreatic Adenocarcinoma

Cholangiocarcinoma

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Lung Neoplasms

Squamous Cell Carcinoma of Head and Neck

Platinum-resistant Ovarian Cancer

Pancreatic Neoplasms

Leiomyosarcoma, Neoplasm Metastasis, Sarcoma

Nasopharyngeal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Clinical Trials

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

TROPHY U-01

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

MK-3475-01E

PANCREAS

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Intravesical Gem/Doce in Patients With NMIBC

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

DVDMS

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

MAGNATE-S

SWITCH

TACTIC

A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

PANC

ISG-ARTICLE

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

HARBOR

ctDNA Lung RCT

ACPC

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC

TARSARC

Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms